Here you will find a summary of Regeneron Pharmaceuticals, Inc.'s latest financial information.
| Latest Earnings Release and 10-Q | Date Filed | Format | Size | |
|---|---|---|---|---|
| Second Quarter Financial Results |  |
N/A | ||
| Form 10-Q | Jul 28, 2010 | 
|
615.5 KB | |
| Form 10-Q | Apr 29, 2010 |
|
487.8 KB | |
| Latest Annual Report and 10-K | Date Filed | Format | Size | |
| 2009 Annual Report and 10K |
|
3.5 MB | ||
| 2008 Annual Report |
|
873.5 KB | ||
| Latest Proxy Statement | Date Filed | Format | Size | |
| Proxy Statement (DEFA14A) | Apr 27, 2010 |
|
30.7 KB | |
| Proxy Statement | Apr 27, 2010 |
|
434.0 KB | |
Stock Information
| NASDAQ:REGN
$23.17 + 0.69 |
Sep 2, 2010
11:30 AM ET |
Quotes delay at least 20min., by eSignal.
